Registered entities
Jaguar Gene Therapy, LLC
Reg. No. 20221388717United States
Innovation
7 patent families — focus: Human necessities, Chemistry & metallurgy, Operations & transport; filing pace accelerating. Cited 76 times.
| Year | Filings |
|---|---|
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 6 |
Social engagement
Social engagement: 12.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
7 investors on record; lead investors include Samsung Venture Investment, T1D Fund, Lilly, Deerfield.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 43% |
| Private equity | 1 | 14% |
| Bank & private debt | 2 | 29% |
| Other / undisclosed | 1 | 14% |
Recent activity
19 May 2026
Event
ASGCT2026
7 Apr 2026
Event
Day of Learning